MULTIPLE-SCLEROSIS - PATHOGENESIS AND TREATMENT

被引:8
作者
BANSIL, S [1 ]
TOIANO, R [1 ]
ROHOWSKYKOCHAN, C [1 ]
JOTKOWITZ, A [1 ]
DOWLING, PC [1 ]
COOK, SD [1 ]
机构
[1] DEPT VET AFFAIRS MED CTR, NEUROL SERV, E ORANGE, NJ USA
关键词
D O I
10.1055/s-2008-1041072
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:146 / 153
页数:8
相关论文
共 71 条
[1]   LIMITED HETEROGENEITY OF T-CELL RECEPTORS FROM LYMPHOCYTES MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS ALLOWS SPECIFIC IMMUNE INTERVENTION [J].
ACHAORBEA, H ;
MITCHELL, DJ ;
TIMMERMANN, L ;
WRAITH, DC ;
TAUSCH, GS ;
WALDOR, MK ;
ZAMVIL, SS ;
MCDEVITT, HO ;
STEINMAN, L .
CELL, 1988, 54 (02) :263-273
[2]   OPEN CONTROLLED THERAPEUTIC TRIAL OF INTRAVENOUS IMMUNE GLOBULIN IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS [J].
ACHIRON, A ;
PRAS, E ;
GILAD, R ;
ZIV, I ;
MANDEL, M ;
GORDON, CR ;
NOY, S ;
SAROVAPINHAS, I ;
MELAMED, E .
ARCHIVES OF NEUROLOGY, 1992, 49 (12) :1233-1236
[3]  
ALTER M, 1976, LANCET, V1, P456
[4]  
[Anonymous], 1991, Lancet, V337, P441
[5]   SUPPRESSOR CELL-FUNCTION IN MULTIPLE-SCLEROSIS - CORRELATION WITH CLINICAL-DISEASE ACTIVITY [J].
ANTEL, JP ;
ARNASON, BGW ;
MEDOF, ME .
ANNALS OF NEUROLOGY, 1979, 5 (04) :338-342
[6]   COMPARISON OF T8+ CELL-MEDIATED SUPPRESSOR AND CYTOTOXIC FUNCTIONS IN MULTIPLE-SCLEROSIS [J].
ANTEL, JP ;
NICHOLAS, MK ;
BANIA, MB ;
REDER, AT ;
ARNASON, BGW ;
JOSEPH, L .
JOURNAL OF NEUROIMMUNOLOGY, 1986, 12 (03) :215-224
[7]   SERUM SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN CHRONIC PROGRESSIVE, STABLE AND STEROID-TREATED MULTIPLE-SCLEROSIS [J].
BANSIL, S ;
TROIANO, R ;
COOK, SD ;
ROHOWSKYKOCHAN, C .
ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (04) :282-285
[8]   A RANDOMIZED, CONTROLLED TRIAL OF CORTICOSTEROIDS IN THE TREATMENT OF ACUTE OPTIC NEURITIS [J].
BECK, RW ;
CLEARY, PA ;
ANDERSON, MM ;
KELTNER, JL ;
SHULTS, WT ;
KAUFMAN, DI ;
BUCKLEY, EG ;
CORBETT, JJ ;
KUPERSMITH, MJ ;
MILLER, NR ;
SAVINO, PJ ;
GUY, JR ;
TROBE, JD ;
MCCRARY, JA ;
SMITH, CH ;
CHROUSOS, GA ;
THOMPSON, HS ;
KATZ, BJ ;
BRODSKY, MC ;
GOODWIN, JA ;
ATWELL, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :581-588
[9]  
BENNUN A, 1991, P NATL ACAD SCI USA, V88, P2466, DOI 10.1073/pnas.88.6.2466
[10]   A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED, 2-CENTER, PILOT TRIAL OF COP 1 IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS [J].
BORNSTEIN, MB ;
MILLER, A ;
SLAGLE, S ;
WEITZMAN, M ;
DREXLER, E ;
KEILSON, M ;
SPADA, V ;
WEISS, W ;
APPEL, S ;
ROLAK, L ;
HARATI, Y ;
BROWN, S ;
ARNON, R ;
JACOBSOHN, I ;
TEITELBAUM, D ;
SELA, M .
NEUROLOGY, 1991, 41 (04) :533-539